FDA first amendment review
This article was originally published in The Rose Sheet
Executive Summary
Deadline for submitting comments regarding FDA's regulation of commercial speech will be extended 45 days to Sept. 13, agency announces July 3. Public also will have additional 45 days to respond to comments of others with a deadline set for Oct. 28. Extension will be published in upcoming Federal Register notice, FDA says. Agency requested public comment on the constitutionality of its regulation of marketing and advertising of cosmetics, drugs and other products May 16 (1"The Rose Sheet" May 20, 2002, p. 7)...
You may also be interested in...
FDA Commercial Speech Regs Constitutionality Debate Opened By Agency
FDA invites public comments on the constitutionality of its approach to regulating advertising and marketing practices for cosmetics, drugs and other products in a notice appearing in the May 16 Federal Register
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.